Scorpius Holdings Inc., an integrated contract development and manufacturing organization (CDMO), has announced the expected launch of its first cGMP mammalian manufacturing campaign at its San Antonio facility in the third quarter of 2024. Jeff Wolf, CEO of Scorpius, expressed
Scorpius Holdings Inc. has successfully executed its first current Good Manufacturing Practice (cGMP) microbial batches at its San Antonio manufacturing facility. This marks the beginning of the company’s support for clinical manufacturing programs, with future commercial activities in sight. The San
Scorpius an integrated contract development and manufacturing organization (CDMO), is set to expand its operational footprint with the opening of a new storage and testing facility in San Antonio, Texas. The expansion, announced on May 20, 2024, is a strategic
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
